|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.2900 - 1.3400|
|52 Week Range||1.2600 - 7.2000|
|Beta (3Y Monthly)||1.74|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 9, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.50|
Benchmark downgraded the shares of Californian cannabis company KuschCo Holdings Inc. to speculative buy from buy on Friday, and said it expects the still unexplained vape-related lung illness that has killed at least 33 people and sickened 1,479 more to weigh on financial performance. Analyst Mike Hickey cut his stock price target to $5 from $7 and said "elevated regulatory risk" is another potential pressure for the maker of vapes, packaging and other accessories. The stock has fallen 75% in 2019, while the ETFMG Alternative Harvest ETF has fallen 20% and the S&P 500 has gained 19.6%. "We are positive longer term, as we note the vast majority of the THC related vape illness has come from black market; which could accelerate legal cannabis market regulation," the analyst wrote in a note to clients. "Near term, we are cautious over potential bans on the sale of vaping products, as was the view from Massachusetts that has enacted a 4-month block of all sales of e-cigarettes and supplies, including those for nicotine and cannabis." KushCo shares were down 0.8% in early trade.
Impressive traction in its aerospace and process solutions businesses and solid demand for commercial fire products drive Honeywell's (HON) Q3 results.
CYPRESS, CA / ACCESSWIRE / October 10, 2019 / KushCo Holdings, Inc. (OTCQX:KSHB) (''KushCo'' or the ''Company''), the premier producer of ancillary products and services to the cannabis and hemp industries, ...
KushCo Holdings Inc (OTC: KSHB ) stock has lost 72.21% year-to-date. With the company being an important player in the vaping industry, its shares have been hit hard in the last 30 days, with over 1,000 ...
CYPRESS, CA / ACCESSWIRE / October 8, 2019 / KushCo Holdings, Inc. (KSHB) (''KushCo'' or the ''Company''), the premier producer of ancillary products and services to the cannabis and hemp industries, has named Sentia Wellness ("Sentia"), a new hemp-derived CBD company with manufacturing and distribution capabilities, as its first brand partner for its new Retail Services division focused on CBD mass distribution, industry education, and compliance. Sentia will utilize KushCo's partnership with C.A. Fortune, a leading full-service national consumer products sales and marketing agency focused on lifestyle brand partnerships, to activate its Social CBD brand across a variety of retail channels.
Cannabis stocks rise for a third straight day Friday, buoyed by reports that vape sales are rebounding after being hit by the outbreak of a serious lung disease that experts say is directly tied to vaping.
Last week, ending on September 27, the cannabis sector was weighed down by the bears. Sector ETFs broadly ended the week in negative territory.
KushCo Holdings, Inc. (OTC: KSHB) said Thursday it has signed agreements with investors for the purchase and sale of 17.2 million units. Each unit is one common share with a price of $0.001 per share and a warrant to buy half a common share at an offering price of $1.75 per unit.
CYPRESS, CA / ACCESSWIRE / September 26, 2019 / KushCo Holdings, Inc. (KSHB) ("KushCo" or the "Company"), today announced it has entered into definitive agreements with investors for the purchase and sale of 17,197,570 units, with each unit consisting of one share of common stock, par value $0.001 per share, and a warrant to purchase half a share of common stock, at an offering price of $1.75 per unit, pursuant to a registered direct offering. The Company intends to use the net proceeds for working capital and for other general corporate purposes. Jefferies LLC and A.G.P./Alliance Global Partners are acting as co-lead placement agents for the offering.
When asked about the recent announcement involving Convectium/Jacksam, Mr. Ralston commented, "Convectium was founded on the basis that automation, speed, hardware and technology combined for the ancillary cannabis space can really help these manufacturers and retailers make their whole filling and supply chain process much simpler and efficient. Discussing what separates Convectium from some of their competitors, Ralston said, "Right now Convectium, in our opinion, is really leading the way because they check all the boxes for what a company may need when it comes to filling and getting these automation systems set up. SinglePoint Inc. will also be presenting their Pure Hemp Cigarettes next month at NACS on October 1st - 4th at booth 5653.
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK , Sept. 16, 2019 /PRNewswire/ -- Virtual Investor Conferences ...
"Company views product offering as a critical step in combatting the black market and illicit operators" GARDEN GROVE, CA / ACCESSWIRE / September 16, 2019 / KushCo Holdings, Inc. (OTCQX:KSHB) ...
GARDEN GROVE, CA / ACCESSWIRE / September 13, 2019 / KushCo Holdings, Inc. (KSHB) (“KushCo” or the “Company”), today announced that it is reconfirming its annual revenue guidance for its fiscal year ended August 31, 2019 of between $145 million and $150 million in sales. The Company renamed and rebranded itself as “KushCo Holdings, Inc.” The Company’s main operating company subsidiary is now Kush Supply Co. The Company opened its new corporate headquarters in Cypress, California.
/R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/
KushCo Holdings (KSHB) has lagged most of its peers in the past months, as some internal problems and the weakening sentiment for the broader market has caused investors to run to safer plays.That combined with the industry taking a black eye from the CannTrust debacle and fall from favor of Canopy growth, as resulted in the company struggling to gain momentum.Consequently, it has one of the most inexpensive forward price-to-sales ratios in the cannabis sector based upon consensus sales of $242.5 million next year, making its valuation under 1.8x 2020's projected revenue.While the industry and the company aren't out of the woods yet, KushCo is positioned to make a nice upward run when sentiment changes.KushCo has a small, but vocal camp of bullish analysts with positive expectations for its stock. Out of the 3 analysts polled by TipRanks, all 3 rate KSHB a Buy. With a return potential of 105%, the stock's 12-month consensus target price stands at $7.67. (See KSHB's price targets and analyst ratings on TipRanks) Internal challengesA couple of things that have weighed on the company are its need to restate its accounting results, and its fairly recent failure to meet delivery expectations concerning compliant packaging to the Canadian market, which was part of the reason for a bottleneck in the supply chain.What happened concerning the accounting errors was the company had to restate its 2017 and 2018 financial results, causing the market to rightfully question the capability of management.Taken together with some of the negative issues associated with the cannabis industry, along with growing concerns over whether or not the economy is slowing down, it has brought about a disproportionate response from the market toward KushCo, in my opinion.With its fast-growing vaporizer segment and increasing its hydrocarbon gases and solvents unit, the company has diversified its portfolio to the point any weakness in one unit should be offset by strength in another.The good news to me is the issues KushCo has faced shouldn't have any problem being solved. That's important because its vaporizer unit should enjoy increasing sales from the Canadian market in 2020 after Canada allows sales of derivative products, of which vaporizers is one of the more popular.That and the highly fragmented compliance requirements in various municipalities in the U.S., provide a solid long-term growth opportunity for KushCo. Even if there is eventually more uniformity concerning future requirements, it'll take a long time to play out.Also, it works with cannabis growers in 25 countries concerning packaging and branding compliance, making it a potentially very lucrative segment to compete in.Canadian derivativesEven though a number of derivatives will be legalized in Canada during October, it'll take until the last couple of weeks of December 2019 before they will be rolled out. For that reason KushCo and others won't get much immediate benefit from it until the first calendar quarter of 2020.With a solid vaporizer unit, KushCo is well positioned to generate significant revenue from legalization in the Canadian market, as it's one of the more popular ways to consume cannabis in the country.This should help the bottom line of KushCo, which in the last quarter fell to a net loss of $10.6 million, down from the $9.2 million loss in the same reporting period last year.The reason why that should improve is vaporizers and other derivative products command higher prices and margins.With its consistent revenue growth, which in the last quarter soared to $41.5 million, a gain of 221 percent year-over-year, the company would get a huge boost in its share price if it is able to continue to grow sales while showing a clear path to profitabilty in the not-too-distant future.As for its hydrocarbon gases and solvents division, that will probably take longer to grow, but with gas in particular being used in the production process of oils - which also generate higher prices and margins - the company has a connection to the oils market that should be a solid niche market in the future.ConclusionKushCo has been a victim of its own accounting errors and temporary failure to deliver on expected compliant packaging in the past. I think both of those are easily solvable, and we should hear from the company that they are problems it has solved.The cannabis market is still under some pressure from the various perceived economic issues at the global level, but it appears the sentiment is improving some, and once that turns around and the market starts to see the potential growth trajectory of KushCo, along with the supplying of new products that will bring it closer to profitability, it's going to be considered one of the most undervalued cannabis stocks available.As the cannabis market sits today, which should last long into the future, KushCo, assuming it executes well, has the product lines in place to enjoy a long upward growth in sales, which will ultimately be done at a profit. I think patient investors are going to be rewarded well.The one caveat is it must show it has control of its accounting numbers in the future. Any further failure there would make it hard for the company to retain faith in its competence.Visit TipRanks’ Trending Stocks page, and find out what companies Wall Street’s top analysts are looking at now.Disclosure: None
As investors, traders and followers of the markets, we can all look back and lament the Apple stock (or the proverbial stock fish of your choice) that got away. Want to learn more about cannabis stocks and where the industry is headed? The cannabis industry is big now, and it’s going to be a lot larger than many realize.
GARDEN GROVE, Calif. , Sept. 9, 2019 /PRNewswire/ -- KushCo Holdings, Inc. (OTCQX: KSHB) (''KushCo'' or the ''Company''), today announced that Nick Kovacevich , Chief Executive Officer and Chairman, will ...
Since Canada enacted nation-wide legalization of marijuana in October 2018, cannabis companies have been the hot new thing in stock investing. But sometimes, that hot new thing isn’t always hot. The cannabis sector has seen a sharp decline in recent months. Major players, like Canopy Growth (CGC) and Aurora Cannabis (ACB), are down by a third or more since the spring. The reasons are varied – licensing bottlenecks in Health Canada, supply and distribution difficulties in a new market, management turnover at Canopy – but the result is clear: the big cannabis companies are not delivering results so far.But there is still money to be made in the cannabis industry. The product is in demand; the problems the big suppliers face are more in the nature of growing pains. So, to profit, investors will benefit by thinking outside of the grow house. We’ve dipped into TipRanks’ stock database and found three companies that are thriving as service providers for the cannabis industry. Innovative Industrial Properties (IIPR)This company is a Real Estate Investment Trust (REIT), focused on the cannabis industry. Innovative buys and manages industrial properties which it then leases to cannabis growers. It’s a profitable model, and the company’s Q2 earnings result bear that out. IIRP reported gains of 155% in both revenues and net income, with the former coming in at $8.28 million and the latter at $3.07 million. EPS, at 30 cents, was up 76%.According to Exec. Chairman Alan Gold, IIPR has operations in 26 states, with over 2 million square feet leased long-term to cannabis growers. The average remaining lease term is over 15 years, and the properties have a current blended yield of 14.6%. CEO Paul Smithers noted that industry analysts see plenty of momentum in cannabis. In his comments on the earnings, he quoted sources projecting “a 35% increase in US regulated cannabis sales from 2018 to 2019, and reaching nearly $30 billion by 2023.” The current operations, and the prospects for near-term growth, provide IIPR with both a solid foundation and an upbeat outlook.In an added boon for investors, IIPR has been paying out a quarterly dividend over the past two years, with regular increases in the disbursement. The current yield is 2.16%, and the payment is $1.80 annualized. The July quarterly payment of 60 cents per share marked a 140% increase year-over-year.Right now, IIPR has one analyst rating, from James Sullivan of BTIG. Sullivan, a 4-star analyst, leads the REIT research team at BTIG. He gives IIPR a $151 price target, suggesting an impressive 81% upside. It’s a clear sign of confidence in the real estate aspect of the cannabis industry. Scotts Miracle-Gro Company (SMG)Land is important, but cannabis industry relies on increasing production and multiple harvests per year to maximize revenue. This requires greenhouses and other controlled growing facilities – letting the plants grow wild outdoors simply won’t cut it. And greenhouses are where Scotts Miracle-Gro comes in.The company may be best known for its Miracle-Gro weed killer and other home gardening products, but its Hawthorne subsidiary is deeply involved in the cannabis industry. Where IIPR provides the real estate needed by the growers, Scotts provides the hydroponic and lighting systems necessary for large-scale indoor cultivation of cannabis. In fact, the company’s annual sales growth of hydroponic systems has outpaced that of traditional lawn and garden gear for the last three years. In a 2016 interview, CEO Jim Hagedorn laid out a vision of marijuana ancillary products as the future of his company: “We’re doing it. It’s beyond stopping. And we’re not getting into pot growing. We’re talking dirt, fertilizer, pesticides, growing systems, lights. You know it’s a multibillion-dollar business...”Hagedorn’s bullish stand on cannabis has borne fruit. SMG’s fiscal Q3 earnings, reported at the end of July, showed a 14% positive surprise – EPS came in at $3.11 against a forecast of $2.71. The Q3 earnings were up 16% from the year-ago quarter. Shares in SMG are up 76% year-to-date.Despite the strong earnings and the increasing sales in grow supplies, the most recent analyst takes on SMG are exact opposites. Merrill Lynch’s Christopher Carey gives the stock a Sell rating, and a low price target of $96. He bases his stance on the declining outlook in cannabis stocks over the last two quarters.5-star analyst William Chappell, of SunTrust Robinson, sees a better future for SMG. He gives the stock a Buy rating, raised his price target by 20%, to $120. He writes, “The continued profitability progression in the Hawthorne segment is an important factor for the stock in quarters to come.” Chappell’s price target suggests a 10% upside to SMG stock.Shares in SMG are selling for $108.50, just above the $108 average target. SMG is up 5.6% since its July 31 Q3 earnings report. KushCo Holdings, Inc. (KSHB)Land and growing facilities aren’t the only support services that the cannabis industry needs. Containers, packaging, and vaporizer products are essential for the medical cannabis segment, for shipping the product and for customer use. KushCo fills this need for the industry.Supporting the cannabis industry has been lucrative. KushCo reported record earnings in its fiscal Q3, of $41.5 million. On the down side, the company is operating at a loss, and reported a net loss per share of 12 cents. This was an improvement of 2 cents per share from the year-ago quarter. As a mitigating factor to the earnings loss, KushCo reported $21.2 million in available cash in May, a gain of $7.7 million since the start of the company’s fiscal year.Wall Street’s analysts were generally pleased by KSHB’s quarterly performance. Benchmark analyst Mike Hickey saw fit to initiate coverage of the stock with a Buy rating and a $7 price target, suggesting an upside of 83%.Writing from Northland Securities, analyst Greg Gibas gave a clear reason for optimism in KSHB: “We believe KSHB will continue to benefit from growing & deepening its customer relationships while also cross-selling throughout its customer base as the company continues to power the global cannabis ecosystem.” His $8 target implies a high upside of 109%. Scott Fortune, of Ross Capital, also gave the stock an $8 target, and added, “The company reaffirmed its $150M FY19 annual revenue target with an emphasis on doubling revenues next quarter and new states being added to its list. Canada's cannabis 2.0 is also expected to come online in 4Q19 and contribute meaningfully to its top line.”These three reviews give KSHB its consensus rating of Strong Buy. The average price target, $7.67, suggests an upside potential of 100% from the current share price of $3.82.Visit TipRanks’ Top Stocks page, and find the most recommended stocks from Wall Street’s best analysts.
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Sept. 6, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications ...
The legalization of cannabis has created a multibillion-dollar market with a huge potential. In the rush to take advantage of this growth, thousands of investors are piling into dozens of public cannabis companies. Luckily, there are plenty of companies to choose from, ranging from large producers like Canopy Growth Corp (NYSE: CGC) and Tilray Inc. (NASDAQ: TLRY to providers of ancillary services like KushCo Holdings Inc (OTC: KSHB) and Innovative Industrial Properties Inc (NYSE: IIPR).